Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 CAD | -4.23% | -4.23% | -12.82% |
Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call | |
Mar. 14 | Microbix Says Clot-Buster Drug Project Advancing | MT |
Sales 2024 * | 18.59M 25.55M | Sales 2025 * | 21.32M 29.31M | Capitalization | 34.01M 46.74M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.83 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
17
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.65% |
Latest transcript on Microbix Biosystems Inc.
1 day | -4.23% | ||
1 week | -4.23% | ||
Current month | -6.85% | ||
1 month | -9.33% | ||
3 months | -20.93% | ||
6 months | +17.24% | ||
Current year | -12.82% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
James Currie
DFI | Director of Finance/CFO | - | 16-10-31 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 90-09-30 |
Peter Blecher
BRD | Director/Board Member | - | 05-12-05 |
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.34 | -4.23% | 68,486 |
24-04-18 | 0.355 | +1.43% | 5,500 |
24-04-17 | 0.35 | 0.00% | 50,500 |
24-04-16 | 0.35 | 0.00% | 15,026 |
24-04-15 | 0.35 | -1.41% | 46,025 |
Delayed Quote Toronto S.E., April 19, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 35.48M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- MBX Stock